AAAAAA

   
Results: 1-8 |
Results: 8
Labdane type diterpenes down-regulate the expression of c-Myc protein, butnot of Bcl-2, in human leukemia T-cells undergoing apoptosis
Authors: Dimas, K Demetzos, C Vaos, V Ioannidis, P Trangas, T
Citation: K. Dimas et al., Labdane type diterpenes down-regulate the expression of c-Myc protein, butnot of Bcl-2, in human leukemia T-cells undergoing apoptosis, LEUK RES, 25(6), 2001, pp. 449-454
C-myc and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors
Authors: Ioannidis, P Trangas, T Dimitriadis, E Samiotaki, M Kyriazoglou, I Tsiapalis, CM Kittas, C Agnantis, N Nielsen, FC Nielsen, J Christiansen, J Pandis, N
Citation: P. Ioannidis et al., C-myc and IGF-II mRNA-binding protein (CRD-BP/IMP-1) in benign and malignant mesenchymal tumors, INT J CANC, 94(4), 2001, pp. 480-484
Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients
Authors: Scorilas, A Karameris, A Arnogiannaki, N Ardavanis, A Bassilopoulos, P Trangas, T Talieri, M
Citation: A. Scorilas et al., Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negative patients, BR J CANC, 84(11), 2001, pp. 1488-1496
Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer
Authors: Scorilas, A Talieri, M Ardavanis, A Courtis, N Dimitriadis, E Yotis, J Tsiapalis, CM Trangas, T
Citation: A. Scorilas et al., Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer, CANCER RES, 60(19), 2000, pp. 5427-5433
Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis
Authors: Scorilas, A Yotis, J Pateras, C Trangas, T Talieri, M
Citation: A. Scorilas et al., Predictive value of c-erbB-2 and cathepsin-D for Greek breast cancer patients using univariate and multivariate analysis, CLIN CANC R, 5(4), 1999, pp. 815-821
The polyadenylation inhibitor cordycepin (3 ' dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels
Authors: Ioannidis, P Courtis, N Havredaki, M Michailakis, E Tsiapalis, CM Trangas, T
Citation: P. Ioannidis et al., The polyadenylation inhibitor cordycepin (3 ' dA) causes a decline in c-MYC mRNA levels without affecting c-MYC protein levels, ONCOGENE, 18(1), 1999, pp. 117-125
Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis
Authors: Scorilas, A Trangas, T Yotis, J Pateras, C Talieri, M
Citation: A. Scorilas et al., Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis, BR J CANC, 81(8), 1999, pp. 1385-1391
Poly(A)polymerase activity levels in breast tumour cytosols
Authors: Scorilas, A Courtis, N Yotis, J Talieri, M Michailakis, M Trangas, T
Citation: A. Scorilas et al., Poly(A)polymerase activity levels in breast tumour cytosols, J EXP CL C, 17(4), 1998, pp. 511-518
Risultati: 1-8 |